|

The ACC Preclinical Research Platform for Precision Oncology

RECRUITINGSponsored by Fondazione del Piemonte per l'Oncologia
Actively Recruiting
SponsorFondazione del Piemonte per l'Oncologia
Started2023-06-05
Est. completion2024-06-01
Eligibility
Age14 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06339541

Summary

The ACC Preclinical Research Platform for Precision Oncology is a retrospective and prospective observational study focused on the implementation and validation of the application of PDCM (Patient Derived Cancer Models) generated from tissues or cells of patients with neoplastic disease, as a tool to improve molecular and biological knowledge of tumours and to test the efficacy and sensitivity of pharmacological treatments.

Eligibility

Age: 14 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients, including paediatric patients, with solid and haematological malignancies for whom tissue or tumour cell material is available.

Exclusion Criteria:

* none

Conditions3

CancerHematologic NeoplasmsSolid Tumor

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.